Oral Oncolytics Play Vital Role in the Treatment of Neuroendocrine Tumors

Video

Mei Ka Fong, PharmD, BCOP, said oral oncolytics have traditionally always been a major part of the treatment for neuroendocrine tumors.

With a growing focus on oral oncolytics across the oncology spectrum, Mei Ka Fong, PharmD, BCOP, said oral oncolytics have traditionally always been a major part of the treatment for neuroendocrine tumors.

In an interview with Pharmacy Times about her presentation at the North American Neuroendocrine Tumor Society (NANETS) 2021 neuroendocrine tumor (NET) Medical Symposium, Fong said the only exceptions to the widespread use of oral oncolytics for NETs are commonly used somatostatin analogue injections, which are administered once a month, and potential intravenous drugs for patients with poorly differentiated tumors.

Related Videos
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit: Sergey | stock.adobe.com - Unhappy woman with insomnia lying on bed next to alarm clock at night
Image credit:  Chanintorn.v | stock.adobe.com - PTSD Mental health concept, Psychologist sitting and touch hand young depressed asian man for encouragement near window with low light environment.Selective focus.
© 2024 MJH Life Sciences

All rights reserved.